“Diagnostic tests inform 70-80% of healthcare decisions. They also account for a significant portion of the sector’s waste and carbon footprint. With the environmental impact of healthcare facing greater scrutiny, there’s a strong case for enhancing R&D with sustainability considerations. Handled well, this can have a positive impact across both environmental and commercial performance. 

As the sector starts to consider sustainability alongside patient safety, there are new commercial opportunities for companies that can strike an effective balance.”

Read the article by Sagentia Innovation’s Medical CTO, Dr Nick Collier in Medical Plastic News here.